2+ day, 21+ hour ago   (222+ words) Ainnocence Inc., an AI-driven drug discovery company, announced new results for AINN-P1, a purpose-built protein foundation model designed to deliver efficient and transferable predictions for protein engineering and biologics discovery. Transformer all-to-all attention (left) requires n² connections; mLSTM recurrent state passing…...

2+ day, 23+ hour ago   (221+ words) Ginkgo plans to build the automation hardware and control software for ESCALATOR, a continuous-flow, autonomous manufacturing system designed to produce and quality-release RNA drug products at patient scale Ginkgo’s Role: Making Twenty Instruments Behave as One System Ginkgo is building…...

3+ day, 7+ hour ago   (401+ words) BioSpace Applying artificial intelligence and automation tactics has played a large role in talent strategy conversations in the past few years While many organizations initially focused on experimenting with tools and driving adoption to create efficiencies, leading employers are now…...

3+ day, 10+ hour ago   (561+ words) BioSpace Tempus Secures Up to $9.5 Million in ARPA-H ADVOCATE Funding to Deploy First Autonomous AI in Cardiology The Initiative Will Pioneer an AI Agent That Functions as an Extension of the Clinician Team, Capable of Delivering and Coordinating Cardiovascular Care…...

3+ day, 22+ hour ago   (263+ words) Trialbee continues to bring fresh innovation to clinical trials with its Honey Platform™, demonstrating how AI is reshaping patient recruitment – and where it goes from here MALMO, Sweden & WILMINGTON, Del.--(BUSINESS WIRE)--Trialbee, the global patient recruitment leader reimagining clinical…...

4+ day, 12+ hour ago   (478+ words) biospace.com Leveragen Secures Australian Patent for Singularity Platform Advancing Fully Human Single-Domain Antibody Discovery A minimalist immune system enables high-fidelity, format-native discovery through high-throughput, sequence-first workflows BOSTON--(BUSINESS WIRE)--#ADCs--Leveragen, Inc., a Boston-based biotechnology company advancing in vivo…...

5+ day, 9+ hour ago   (326+ words) As a medicinal chemist, physician and machine learning (ML) scientist, I believe that AI will shift the nature of our drug design and development work, but not in the ways widely being presented. AI approaches will change the way we study…...

5+ day, 10+ hour ago   (1029+ words) The hunt for a therapy that can alter the course of Parkinson’s disease has been long and arduous, riddled with failed attempts and existential questions about the best way to approach the complex neurological condition. Now, several drugmakers are taking…...

1+ week, 4+ day ago   (208+ words) BioSpace Verasonics Announces International Patent Grants and New Provisional Patent Application for Advanced Ultrasound Transceiver Technology KIRKLAND, Wash.--(BUSINESS WIRE)--#FocusedUltrasound--Verasonics, Inc., the leader in research ultrasound, today announced patent grants in Canada, China, Israel, Japan, and Korea for…...

1+ week, 4+ day ago   (289+ words) BioSpace BenchSci Announces Two-Year Enterprise Agreement with argenx to Advance AI-Driven Preclinical Drug Discovery Scientist-led competitive selection deepens BenchSci's presence in European biopharma TORONTO--(BUSINESS WIRE)--BenchSci, a leading provider of AI software for biopharma research and development, today announced…...